XML 72 R58.htm IDEA: XBRL DOCUMENT v3.23.1
Note 14 - Subsequent Events (Details Textual) - USD ($)
3 Months Ended 11 Months Ended 12 Months Ended
Mar. 21, 2023
Jan. 09, 2023
Dec. 20, 2022
Mar. 29, 2023
Dec. 13, 2022
Dec. 31, 2022
Dec. 31, 2021
Mar. 06, 2023
Jan. 01, 2023
Mar. 31, 2021
Mar. 01, 2021
Proceeds from Issuance of Common Stock           $ 3,617,000 $ 4,882,000        
Share Price (in dollars per share)           $ 0.20 $ 0.20        
Note Payable, Maturing March 8, 2023 [Member]                      
Debt Instrument, Face Amount                   $ 50,000 $ 50,000
Warrants Issued with 2020 Unit Offering [Member] | Minimum [Member]                      
Warrants and Rights Outstanding, Term (Year)           6 months 6 months        
Warrants Issued with 2020 Unit Offering [Member] | Maximum [Member]                      
Warrants and Rights Outstanding, Term (Year)           5 years 5 years        
Clyra Medical [Member]                      
Stock Issued During Period, Shares, New Issues (in shares)             161        
Shares Issued, Price Per Share (in dollars per share)     $ 310     $ 310 $ 310        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)           1,829 2,594        
Series A Preferred Stock [Member] | Clyra Medical [Member]                      
Stock Issued During Period, Shares, New Issues (in shares)     725                
Shares Issued, Price Per Share (in dollars per share)     $ 372                
Lincoln Park Capital Fund, LLC [Member]                      
Stock Issued During Period, Shares, New Issues (in shares)         6,011,701 6,011,701 24,255,920        
Proceeds from Issuance of Common Stock         $ 1,253,000 $ 1,253,000 $ 4,018,000        
Subsequent Event [Member]                      
Stock Issued During Period, Shares, New Issues (in shares)       3,500,000              
Common Stock, Share Subscribed but Unissued, Subscriptions Receivable       $ 694,640              
Subsequent Event [Member] | Conversion of Clyra Medical Stock Into Biolargo Common Stock [Member]                      
Conversion of Stock, Shares Converted (in shares)   322                  
Conversion of Stock, Shares Issued (in shares)   527,983                  
Conversion of Stock, Conversion Price (in dollars per share)   $ 0.1894                  
Subsequent Event [Member] | Chief Financial Officer [Member]                      
Engagement Extension, Term (Year) 1 year                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Per Month (in shares) 25,000                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) 300,000                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares (in shares) 25,000                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Monthly, Number of Shares (in shares) 25,000                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in dollars per share) $ 0.20                    
Subsequent Event [Member] | Chief Financial Officer [Member] | Share-Based Payment Arrangement, Option [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year) 10 years                    
Subsequent Event [Member] | BioLargo Energy Technologies, Inc (BETI) [Member]                      
Noncontrolling Interest, Ownership Percentage by Parent       96.80%              
Subsequent Event [Member] | BioLargo Energy Technologies, Inc (BETI) [Member]                      
Stock Issued During Period, Shares, New Issues (in shares)       350,000              
Share Price (in dollars per share)                 $ 2.00    
Proceeds from Issuance or Sale of Equity, Total       $ 700,000              
Subsequent Event [Member] | Warrants Expiring Six Month After Investment Date [Member]                      
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares)       3,500,000              
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)       $ 0.228              
Subsequent Event [Member] | Warrants Expiring Six Month After Investment Date [Member] | Minimum [Member]                      
Warrants and Rights Outstanding, Term (Year)       6 months              
Subsequent Event [Member] | Warrants Issued with 2020 Unit Offering [Member]                      
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)       $ 0.285              
Subsequent Event [Member] | Warrants Issued with 2020 Unit Offering [Member] | Maximum [Member]                      
Warrants and Rights Outstanding, Term (Year)       5 years              
Subsequent Event [Member] | Warrants Expiring Five Years After Investment Date [Member]                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)       3,787,579              
Subsequent Event [Member] | Warrants Issued to Holder of a 50,000 Note [Member]                      
Warrants and Rights Outstanding, Term (Year)               5 years      
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)               $ 0.21      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)               200,000      
Subsequent Event [Member] | Clyra Medical [Member] | Warrant [Member]                      
Shares Issued, Price Per Share (in dollars per share)       $ 372              
Warrants and Rights Outstanding, Term (Year)       3 years              
Subsequent Event [Member] | Biolargo [Member] | BioLargo Energy Technologies, Inc (BETI) [Member]                      
Proceeds from Issuance or Sale of Equity, Total       $ 100,000              
Subsequent Event [Member] | Series A Preferred Stock [Member] | Clyra Medical [Member]                      
Stock Issued During Period, Shares, New Issues (in shares)       726              
Preferred Stock, Shares Subscribed but Unissued, Subscriptions Receivable       $ 225,000              
Shares Issued, Price Per Share (in dollars per share)       $ 310              
Subsequent Event [Member] | Lincoln Park Capital Fund, LLC [Member]                      
Stock Issued During Period, Shares, New Issues (in shares)       545,402              
Proceeds from Issuance of Common Stock       $ 105,000